BioCentury
ARTICLE | Clinical News

MDX-240: Will add an ongoing Belgian study

December 12, 1994 8:00 AM UTC

Medarex Inc. (MEDX), Princeton, N.J. Product: MDX-240 bispecific antibody targeted at killer T cells and an HIV protein expressed on infected cells Indication: HIV infection Status: Will add a French ...